Profound Medical Corp.

Profound Medical Corp. is a commercial-stage medical technology company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the ablation of diseased tissue. Its flagship TULSA-PRO system provides customizable treatment for prostate cancer and BPH, while Sonalleve offers non-surgical options for uterine fibroids and bone metastases. The company aims to provide safe, minimally invasive treatment options that preserve patients' quality of life.